New air purifier reduces the spread of superbugs in hospitals

Photocatalytic biocide reactor eliminates viral, fungal and bacterial pathogens from the air

The new Airocide DS air purifier from Seal Shield is a tabletop or bedside air purification product that uses a unique photocatalytic biocide reactor to eliminate viral, fungal and bacterial pathogens from the air. Developed by NASA, Airocide converts dangerous bacteria, viruses and destructive VOCs into harmless water vapour without producing ozone or other harmful by-products. Filter-less and energy efficient, Airocide DS produces air that is 99.999% pathogen-free.

As hospitals and other healthcare facilities struggle with the spread of superbugs that contribute to fatal hospital-acquired infections, new evidence shows that HVAC systems may actually be contributing to the transmission of disease, as indicated by ASHRAE (the American Society of Heating, Refrigerating and Air-Conditioning Engineers).

Hospitals manage airborne infectious disease routes by relying on laminar flow diverters, room pressure differentials and HEPA filtration. HEPA filtration's effectiveness is determined by its ability to capture particles sized 0.3µm and above. However, many pathogens are considerably smaller than 0.3µm, including MRSA (0.08), C. difficile (0.07), the influenza virus (0.095) and pneumonia (0.15), to name a few.

Seal Shield's Airocide DS filter-less technology destroys all organic matter, including bacteria and viruses smaller than 0.3µm. In fact, Airocide's eradication capabilities extend down to the smallest organic particles in existence — gas molecules measured in angstrom units.

Airocide even reduces surface contamination by removing airborne organisms that settle on fomites. The Airocide DS protects the environment by continuously cleaning the air 24 hours a day, every day.

Companies